REMY: Clinical Research on Hypertrophic Cardiomyopathy - Longitudinal Study on Patients with Hypertrophic Cardiomyopathy

Head :
Hagège Albert, CHU Paris Ouest - Hôpital Européen Georges Pompidou

Last update : 07/08/2015 | Version : 1 | ID : 8665

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Longitudinal Study on Patients with Hypertrophic Cardiomyopathy
Sign or acronym REMY: Clinical Research on Hypertrophic Cardiomyopathy
General Aspects
Medical area Cardiology
Health determinants Genetic
Keywords patient treatment, HCM, family, profile, diagnosis, assessment, therapy
Scientific investigator(s) (Contact)
Name of the director Hagège
Surname Albert
Address 20 Rue Leblanc 75908 PARIS CEDEX 15 FRANCE
Phone +33 (0)1 56 09 36 83
Email albert.hagege@egp.aphp.fr
Unit CHU Paris Ouest - Hôpital Européen Georges Pompidou
Organization Hôpital Européen Georges
Collaborations
Funding
Funding status Private
Details French Cardiology Society.
Governance of the database
Sponsor(s) or organisation(s) responsible French Cardiology Society.
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. 26 centres on 20/06/2014.
Database objective
Main objective To establish an observatory for the treatment of patients with hypertrophic cardiomyopathy (sarcomeric or non-sarcomeric). To specify the profile of HCM patients in France, methods for diagnosis and assessment (etiological and family survey), and therapeutic procedures.
Inclusion criteria - Aged 15 years or over;
- with HCM (non-valvular) defined by ultrasound with left ventricle thickness greater or equal to 13 mm (familial) or greater or equal to 15 mm (sporadic);
- Patient was informed and gave their consent.

Exclusion criteria:
- Under 15 years old;
- Significant aortic stenosis (less than 1 cm²).
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 01/2010
Date of last collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1,007 (20/06/2014).
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data HCM etiology, Doppler ultrasound, history of hospitalisation, treatment, complications.
Declarative data (detail) Paper self-questionnaire
Details of collected declarative data Personal and family history, treatments.
Paraclinical data (detail) ECG, MRI, scan, electrophysiological examination, cardiac catheterisation, biopsy.
Biological data (detail) BNP, NT-Pro BNP, troponin, CPK, creatinine, haemoglobin, high-sensitivity CRP, iron level, TSH, serum calcium, serum protein electrophoresis, α-galactosidase A assay.
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Health care consumption and services
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Medicines consumption
Procedures
Participant monitoring Yes
Details on monitoring of participants Follow-up at 18 months, 3 years and 5 years.
Links to administrative sources No
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) Contact the scientist in charge.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05